163 related articles for article (PubMed ID: 12509077)
41. A case of feline primary inflammatory mammary carcinoma: clinicopathological and immunohistochemical findings.
Millanta F; Verin R; Asproni P; Giannetti G; Poli A
J Feline Med Surg; 2012 Jun; 14(6):420-3. PubMed ID: 22408148
[TBL] [Abstract][Full Text] [Related]
42. Skeletal metastasis in feline mammary carcinoma: case report and literature review.
Waters DJ; Honeckman A; Cooley DM; DeNicola D
J Am Anim Hosp Assoc; 1998; 34(2):103-8. PubMed ID: 9507421
[TBL] [Abstract][Full Text] [Related]
43. Role of CXCR4 and SDF-1 in mammary tumor metastasis in the cat.
Oonuma T; Morimatsu M; Nakagawa T; Uyama R; Sasaki N; Nakaichi M; Tamamura H; Fujii N; Hashimoto S; Yamamura H; Syuto B
J Vet Med Sci; 2003 Oct; 65(10):1069-73. PubMed ID: 14600343
[TBL] [Abstract][Full Text] [Related]
44. [Metastasis of a mammary carcinoma in the central nervous system of a cat].
Atasever A; Kul O
Dtsch Tierarztl Wochenschr; 1996 Nov; 103(11):472-4. PubMed ID: 9081821
[TBL] [Abstract][Full Text] [Related]
45. Differential expression of CXCR4 receptor in early and term human placenta.
Kumar A; Kumar S; Dinda AK; Luthra K
Placenta; 2004 Apr; 25(4):347-51. PubMed ID: 15028427
[TBL] [Abstract][Full Text] [Related]
46. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
[TBL] [Abstract][Full Text] [Related]
47. Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo.
Sun YX; Wang J; Shelburne CE; Lopatin DE; Chinnaiyan AM; Rubin MA; Pienta KJ; Taichman RS
J Cell Biochem; 2003 Jun; 89(3):462-73. PubMed ID: 12761880
[TBL] [Abstract][Full Text] [Related]
48. Molecular phenotype of primary mammary tumours and distant metastases in female dogs and cats.
Beha G; Muscatello LV; Brunetti B; Asproni P; Millanta F; Poli A; Benazzi C; Sarli G
J Comp Pathol; 2014; 150(2-3):194-7. PubMed ID: 24060151
[TBL] [Abstract][Full Text] [Related]
49. Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer.
Lee HJ; Kim SW; Kim HY; Li S; Yun HJ; Song KS; Kim S; Jo DY
Int J Oncol; 2009 Feb; 34(2):473-80. PubMed ID: 19148483
[TBL] [Abstract][Full Text] [Related]
50. Hormonal background of canine and feline mammary tumours.
Rutteman GR; Misdorp W
J Reprod Fertil Suppl; 1993; 47():483-7. PubMed ID: 8229967
[TBL] [Abstract][Full Text] [Related]
51. Distribution of CCR3 mRNA expression in horse tissues.
Weston MC; Cunningham FM; Collins ME
Vet Immunol Immunopathol; 2006 Dec; 114(3-4):238-46. PubMed ID: 16979246
[TBL] [Abstract][Full Text] [Related]
52. Immunohistochemical detection of Mdm2 and p53 in feline mammary gland tumors.
Nakano M; Wu H; Taura Y; Inoue M
J Vet Med Sci; 2006 May; 68(5):421-5. PubMed ID: 16757883
[TBL] [Abstract][Full Text] [Related]
53. The role of vascular endothelial growth factor and its receptor Flk-1/KDR in promoting tumour angiogenesis in feline and canine mammary carcinomas: a preliminary study of autocrine and paracrine loops.
Millanta F; Silvestri G; Vaselli C; Citi S; Pisani G; Lorenzi D; Poli A
Res Vet Sci; 2006 Dec; 81(3):350-7. PubMed ID: 16556453
[TBL] [Abstract][Full Text] [Related]
54. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
55. Expression levels of the focal adhesion-associated proteins paxillin and p130CAS in canine and feline mammary tumors.
Scibelli A; d'Angelo D; Pelagalli A; Tafuri S; Avallone L; Della Morte R; Staiano N
Vet Res; 2003; 34(2):193-202. PubMed ID: 12657211
[TBL] [Abstract][Full Text] [Related]
56. Prognostic histopathological and molecular markers in feline mammary neoplasia.
Hughes K; Dobson JM
Vet J; 2012 Oct; 194(1):19-26. PubMed ID: 22841451
[TBL] [Abstract][Full Text] [Related]
57. Human telomerase reverse transcriptase mRNA is highly expressed in normal breast tissues and down-regulated in ductal carcinoma in situ.
Liu J; Baykal A; Fung KM; Thompson-Lanza JA; Hoque A; Lippman SM; Sahin A
Int J Oncol; 2004 Apr; 24(4):879-84. PubMed ID: 15010825
[TBL] [Abstract][Full Text] [Related]
58. CXCR4 and its ligand CXCL12 display opposite expression profiles in feline mammary metastatic disease, with the exception of HER2-overexpressing tumors.
Marques CS; Santos AR; Gameiro A; Correia J; Ferreira F
BMC Cancer; 2018 Jul; 18(1):741. PubMed ID: 30012106
[TBL] [Abstract][Full Text] [Related]
59. Double-label nonradioactive in situ hybridization for the analysis of chemokine receptor expression in the central nervous system.
Li M; Ransohoff RM
Methods Enzymol; 2009; 460():91-103. PubMed ID: 19446721
[TBL] [Abstract][Full Text] [Related]
60. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.
Van den Eynden GG; Van Laere SJ; Van der Auwera I; Merajver SD; Van Marck EA; van Dam P; Vermeulen PB; Dirix LY; van Golen KL
Breast Cancer Res Treat; 2006 Feb; 95(3):219-28. PubMed ID: 16244790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
